![Mark A. Gallop](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark A. Gallop
Fondateur chez
Rubedo Life Sciences, Inc.
Profil
Mark A. Gallop was the founder of XenoPort, Inc. (founded in 1999) where he held the title of Senior Vice President-Research from 1999 to 2009.
He is also the founder of Rubedo Life Sciences, Inc. (founded in 2018) where he currently holds the title of Chairman, Head-Chemistry & Development.
Dr. Gallop's former job(s) include being the Director & Chief Scientific Officer at BlueLight Therapeutics, Inc. He was also the Senior Director-Combinatorial Chemistry at Affymax Research Institute from 1990 to 1999.
Additionally, he served as the Chief Scientific Officer at Nurix Therapeutics, Inc. In terms of education, Dr. Gallop holds a doctorate degree from the University of Cambridge and an undergraduate degree from Auckland University.
Postes actifs de Mark A. Gallop
| Sociétés | Poste | Début |
|---|---|---|
Rubedo Life Sciences, Inc.
 Rubedo Life Sciences, Inc. BiotechnologyHealth Technology Discovers and develops therapeutics & medicines that helps to stay young | Fondateur | 01/01/2018 |
Anciens postes connus de Mark A. Gallop
| Sociétés | Poste | Fin |
|---|---|---|
Affymax Research Institute
 Affymax Research Institute Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Corporate Officer/Principal | 01/01/1999 |
BlueLight Therapeutics, Inc.
 BlueLight Therapeutics, Inc. BiotechnologyHealth Technology Develops novel systems to analyze real-time protein function for research and clinical applications | Directeur Technique/Scientifique/R&D | - |
| NURIX THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | - |
| XENOPORT, INC. | Fondateur | - |
Formation de Mark A. Gallop
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
16
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
BlueLight Therapeutics, Inc.
BlueLight Therapeutics, Inc. BiotechnologyHealth Technology Develops novel systems to analyze real-time protein function for research and clinical applications | Health Technology |
Nurix Therapeutics, Inc.
 Nurix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical stage biopharmaceutical company that discovers, develops and commercializes oral, small molecule therapies for the treatment of cancer & immune disorders | Health Technology |
Affymax Research Institute
Affymax Research Institute Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
XenoPort, Inc.
 XenoPort, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing of pharmaceutical products for the potential treatment of neurological disorders | Health Technology |
Auckland University
 Auckland University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rubedo Life Sciences, Inc.
Rubedo Life Sciences, Inc. BiotechnologyHealth Technology Discovers and develops therapeutics & medicines that helps to stay young | Health Technology |
